Reported Dec 13, 2023 · Ongoing

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak…

Padagis US LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Padagis US LLC · 3940 Quebec Ave N · Minneapolis, MN · 55427-1244

Is this the product you have?

  • Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only
  • Manufactured BySidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand
  • India Distributed ByPadagis, Allegan, MI 49010
  • NDC0574-0118-30
Lot codes and dates
  • Lot
    • 231104
    • 231105
    • 231106
    • exp 7/31/2025
Amount recalled
7,032 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Padagis US LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 3:34 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.